{"chunk_id": "9789241506649_eng__chunk_200", "source": "9789241506649_eng", "text": "ther and infant were examined by the midwife and further care, counselling, \nadvice and medical treatment were provided. The fourth trial, performed in Denmark, \ncompared a synthetic analogue of ergonovine (methylergomtrine 0.2 mg thrice daily for \nthree days) with a placebo (89). The primary aim of this study was to determine the efficacy \n30\nWHO RECOMMENDATIONS ON POSTNATAL CARE OF THE MOTHER AND NEWBORN\nof 72-hour prophylactic oral methylergomtrine in reducing PPH and endometritis during \nthe"}